← Eichor
Study identifier: NCT06762626 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Comparing FET Guided by ERA Vs Standard Timing in Patients with Recurrent Implantation Failure

Condition: Recurrent Implantation Failure · Infertility  ·  Sponsor: The University of Hong Kong

PhaseNA
Planned participants734
Who can joinFemale, 18 Years to 40 Years
Healthy volunteersNo

About this study

The pregnancy rate of in vitro fertilisation (IVF) remains around 35% per transfer. Women who are not pregnant following several embryo transfers are regarded as having recurrent implantation failure (RIF), with one of the causes being the asynchronization of the embryo and endometrium. Endometrial receptivity analysis (ERA) may identify the window of implantation and guide the timing of embryo transfer to improve the pregnancy outcomes. However, there is no randomized controlled trial on the clinical effectiveness of ERA in women with RIF. This is a multicenter double-blind randomized controlled trial. All participants will have an endometrial biopsy for ERA in a standard hormonal treatment cycle. They will then be randomly assigned in the central laboratory into the intervention or control group in a 1:1 ratio. At the transfer cycle, participants in the intervention group will have frozen embryo transfer timed according to the results of ERA while those in the control group will have the transfer according to the standard timing. The primary outcome is the ongoing pregnancy rate at 10-12 weeks at their first frozen embryo transfer.

This description comes directly from the study's public registry record.

Talk to the study team

Ernest HY Ng, MD  ·  +85222553400  ·  nghye@hku.hk

Catherine Hung, MBBS  ·  +85296148198  ·  catherinehmw@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

The University of Hong KongHong Kong, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06762626